Lymph node metastasis in head and neck cancer is a significant prognostic indicator that has a major impact both on treatment planning and patient survival [1]. Because aggressive treatment for primary malignancy has become more advanced, patients often live long enough to experience either recurrence or distant metastasis. Nodal disease and, particularly, its presence on first presentation is the most reliable predictor for both of these phenomena [2e5]. With regard to the natural history of this head and neck cancer, the most common sites of metastasis from positive cervical lymph nodes are the lungs, bones, and liver [6] .
Lymph node metastasis in head and neck cancer is a significant prognostic indicator that has a major impact both on treatment planning and patient survival [1] . Because aggressive treatment for primary malignancy has become more advanced, patients often live long enough to experience either recurrence or distant metastasis. Nodal disease and, particularly, its presence on first presentation is the most reliable predictor for both of these phenomena [2e5] . With regard to the natural history of this head and neck cancer, the most common sites of metastasis from positive cervical lymph nodes are the lungs, bones, and liver [6] .
The rate of metastasis varies among different areas of the aerodigestive tract. For instance, T3/T4 carcinomas of the oral cavity, oropharynx, hypopharynx, and supraglottic larynx exhibit ipsilateral nodal metastasis at a rate of higher than 50% [7] . The rate of either bilateral or contralateral nodal metastasis ranges from 2%-35% [8, 9] . Radiologic identification of nodal disease thus is critical to guide surgical decision making regarding neck dissection because imaging has been shown to identify metastasis in 7.5%-19% of clinically silent nodes [2, 3, 9] .
The identification of nodal disease is important with regard to both the pre-and posttreatment stages. Pretreatment imaging has been shown to identify areas of involvement in the retropharyngeal, high level II, low level IV, low level V, and level VI/VII nodes [7] . As a result, pretreatment computed tomography (CT) or magnetic resonance imaging (MRI) has become a mainstay of the care plan for patients with head and neck cancer. The wide acceptance of the radiologic definition of nodal levels has expedited this transition. Diseased lymph nodes are identified radiologically by their clustering, roundness (shape), inhomogeneity, size, and periphery (extracapsular spread). In addition, the radiologist should be familiar with the most probable sentinel nodes for a given malignancy. For this reason, we propose the acronym ''CRISPS'' (clustering, rounded shape, inhomogeneity, size, periphery, sentinel location) as a comprehensive and easy-to-remember mnemonic to aid the radiologist in identifying nodal involvement in patients with head and neck cancer.
Contrast-enhanced CT represents the ideal modality for the assessment of metastatic lymphadenopathy, followed closely by magnetic resonance (MR) pulse sequences (unenhanced T1 or T2 with fat saturation) [10] . Positron emission tomographyeCT possesses the advantage of metabolic correlation, which can aid both in the setting of equivocal findings and distant disease. However, challenges remain due to its poor sensitivity in the clinically negative neck [11] . Results of several small studies have suggested that diffusion weighted imaging is at least as specific and possibly more sensitive than conventional MRI. It is generally maintained that metastatic nodes will exhibit diffusion restriction in relation to greater cellularity [12] . However, its use in head and neck cancer staging is prone to motion artifact and both inter-and intra-rater discrepancies that have yet to be optimized [13] .
Clustering
Clustered lymphadenopathy is associated with a poorer prognosis than the isolated equivalent. Groups of 3 nodes that measure between 8 and 15 mm in the long axis, or 9-10 mm in the short axis in the jugulodigastric region (level II) and 8-9 mm in the rest of the neck reliably detect metastasis, provided that the nodes are in the drainage area of the primary tumour site ( Figure 1) [1e4, 6, 14] . Accuracy is affected by recent infection, radiation, and/or surgery, all of which can give rise to reactive adenopathy. Clusters should be measured as abutting nodes with no intervening fat planes [15] .
In addition, nodal clustering can be used to heighten suspicion regarding nodes that are borderline in terms of size criteria. This assertion has been corroborated in studies that used fluorodeoxyglucoseepositron emission tomography and MRI, and is most reliable at levels I, II, and III [16] . One study has shown a negative predictive value for metastasis, with an absence of clustering at level II to be 100%. The same study demonstrated a positive predictive value at this level for a cluster of nodes, all more than 1 cm, to be 82.9% [17] . Coincidentally, the behavior of clustering appears to be especially pertinent to head and neck cancer, most notably squamous cell carcinoma. Not only are tumour cells known to cluster in positive lymph nodes as demonstrated in pathologic studies [18] , but it is increasingly clear that gene clusters are responsible for oncogenesis and for susceptibility to metastasis (eg, on chromosomes 7, 9, and 11) [19] .
Rounded Shape
In general terms, an oblong shape is thought to be representative of a normal lymph node, whereas a spherical shape is more likely to be associated with metastasis. Numerous studies now strongly support the criterion of a long-to-short axis ratio less than 2 as representing a node that contains metastatic carcinoma [1e4, 6, 7] . Shape is a crucial aspect to include in the evaluation of a suspicious node because hyperplastic nodes will often meet size criteria but possess a long-to-short axis ratio of more than 2 ( Figure 2 ). This assertion is supported by sonographic studies correlated to fine-needle aspiration evidence [20] . Nodal size on CT and MRI is not always accurate compared with ultrasound, and thus morphologic criteria are especially important. With either of these modalities, a round node may be representative of the aforementioned decrease in a long-to-short axis ratio or equally by eccentric cortical hypertrophy.
The use of shape criteria may be of particular importance in nodes that are not enlarged, and it is important to recognize that spherical nodes are not necessarily hyperplastic. Although shape criteria were designed to be asserted in the context of enlarged nodes, as many as 82%-86% of metastatic lymph nodes may be round but less than 10 mm [21, 22] . Therefore, although roundness alone does not necessarily imply metastasis, it merits suspicion when primary lymphatic drainage is plausible. It should be noted that proper application of this criterion requires assessment of node size both in the axial and in the craniocaudal planes. Pitfalls for reliable application of this criterion include variation in the shape of the nodes, depending on the location of the nodes in the neck and difficulties in reliable application to smaller nodes.
Inhomogeneity
The metastatic lymph node is composed, in varying parts, of tumour cells, native lymph node tissue, and necrosis, and, therefore, can be internally heterogeneous. When reliably identified, typically >3 mm in size, internal nodal heterogeneity, or ''central necrosis,'' represents the most reliable imaging findings of metastatic disease. Most often, this necrosis is centrally located and can be identified as a focus of water attenuation on CT (10-25 HU), with a variably thick and enhancing rim ( Figure 3 ) [14] . On T2-weighted MR, necrotic foci will manifest as areas of higher signal intensity ( Figure 4 ) against a background of intermediate intensity, which represents native node and tumour cells. Because of its decreased specificity for necrosis over a generalized change in density, CT demonstrates a larger area than a corresponding finding on MR. Fast spin echo MRI has been shown to be as reliable as conventional T2-weighted MRI, with the benefit of a faster acquisition time [23] . Despite a comparative decrease in specificity in detecting necrosis, contrast-enhanced CT represents the more sensitive modality overall [3] .
Central necrosis is the imaging finding that is most reliably associated with metastasis and is reported to be present in one-third of all metastatic nodes [6] . In the setting of head and neck cancer, a necrotic node is considered pathologic regardless of size ( Figure 5 ). A potential pitfall exists with spin-echo noncontrast MR, in that T2 hyperintensity can also be seen in hyperplastic nodes [24] . Thus, an MR workup could include both fast spin echo and contrast-enhanced T1-weighted imaging with fat suppression to reveal a central nonenhancing area of necrosis when applicable. Central necrosis is not without a differential diagnosis. Fatty hilar metaplasia, as seen in the setting of long-standing chronic infection, can exhibit similar imaging characteristics. However, these usually are distinguishable from metastatic nodes based on the lack of a rounded configuration and the presence of a reniform or lima-bean shape. If such affected nodes are large enough, they also will show Hounsfield unit measurements that can be measured as true fat density as opposed to necrotic tissue ( Figure 6 ). However, in very small nodes or in cases in which the hilar metaplasia is small and/or located centrally within the node, these may be indistinguishable from metastasis [3] , which, again, highlights the importance of using the full array of diagnostic criteria to obtain the most accurate possible interpretation.
Another feature to consider under the heading of inhomogeneity is the presence of nodal enhancement, the presence of which implies an increase in nodal vascularity. It should be noted that a variety of conditions, for example, the presence of neck infection as well as patients undergoing or having had chemotherapy or radiation therapy can demonstrate nodal enhancement (Figure 7) . In addition, a variety of neoplasms also are known to give rise to vascular metastases. In particular, lymphoma, papillary, and medullar thyroid carcinoma, and Kaposi sarcoma may give rise to enhancing metastatic adenopathy (Figure 8) [25e28]. in a patient with an unknown primary carcinoma. (C) A patient with a carcinoma that involves the right mandibular alveolus (long arrow); note the small right level IIA node (short arrow). Although not considered enlarged by imaging size criteria, this node was noted to be pathologic after neck dissection.
Size
The indications for suspicious lymphadenopathy have advanced beyond the original criteria, while maintaining its foundational theory. Specifically, a node is flagged when its largest dimension, as measured in the axial plane, exceeds 15 mm in level I (submandibular) and II (jugulodigastric) or is in excess of 10 mm at all other locations in the neck [1e3, 9, 14, 29] . Special consideration is given to retropharyngeal nodes, the diameter of which should not exceed 8 mm when viewed in the axial plane ( Figure 9 ) [14, 30] . Size criteria have been noted to be unreliable in the clinically negative neck, and should be used in combination with the other diagnostic criteria as well as with aspiration cytology when available [31] .
Periphery
Subcapsular proliferation is one of the earliest signs of tumour spread, as a result of tumour cell entry into the afferent lymphatics closest to the primary tumour. Although inconsistent, these can be seen in subcapsular nodal regions as foci of low attenuation on contrast-enhanced CT [9] . This phenomenon is then followed by extracapsular tumour spread, often represented on CT as a thickened, irregular nodal rim with associated abnormal contrast enhancement and peripheral ill definition ( Figure 10 ). Pathologic studies report that extracapsular spread is microscopically present in as many as 25% of nodes that do not meet the size criteria for suspicion [2e4,32] . Enlarged lymph nodes smaller than 3 cm have been reported on average to have an incidence of 60% extracapsular spread, whereas nodes larger than 3 cm have been reported at 74% [33e35].
Extracapsular spread is a crucial aspect of pathology for the radiologist to identify because its presence is associated with a 10-fold increase in the likelihood of recurrence Figure 10 . (A-C) Contrast computed tomography images in 3 different patients with metastatic adenopathy. In each case, there is an indistinct peripheral margin to the nodes (arrows), which represents extracapsular extension of tumour into the surrounding tissues. [6, 24] . Moreover, it is imperative that any perceived instance of spread be analysed for further invasion of surrounding vasculature, soft tissue, or bone. Important sources of spread include the internal and common carotid arteries as well as the prevertebral soft tissues. Carotid arterial invasion, in particular, is associated with very poor prognosis, even in the wake of improvements in tumour resection and vascular grafting [36e38]. Although neither CT nor MRI can reliably identify the vessel wall level at which invasion occurs, it is important to note the extent of circumferential involvement because it has been shown that, at more than 270 , invasion is probable ( Figure 11 ) [37] . Also critical in the assessment of suspected extracapsular spread is a thorough review of the patient's history because recent infection, capsular inflammation, and either recent surgical manipulation or irradiation can yield similar findings. MR is less sensitive than CT for the detection of extracapsular tumour spread [39] .
Sentinel Node
In the majority of head and neck cancers (66.7%), the jugulodigastric node represents the sentinel node by way of internal jugular and deep cervical lymphatic drainage [40] . The first point of afferent drainage from the face, mouth, pharynx, and tonsils, the jugulodigastric node is the highest of the level II nodes and is located adjacent to the angle of the mandible. This node is commonly affected by tumours from the oral cavity and oropharynx (Figure 12 ). Tongue-base tumours, in some instances, can bypass the jugulodigastric and other level II nodes and spread directly to an ipsilateral low level III or IV node called the juguloomohyoid node. Thus, in the setting of tongue carcinoma, this node is another example of a sentinel node. Another important example of the use of the ''sentinel'' component of this acronym is in the setting of a head and neck cancer that is known to have a high incidence of nodal disease with what appears to be normal-appearing nodes in the setting of the other imaging criteria, that is, normal size, shape, and internal texture. An example is shown in Figure 13 , which demonstrates a right-sided buccal carcinoma with 2 ipsilateral level IB nodes. These nodes only show mild prominence because they still measure less than 1.5 cm but their radiographic suspicion is increased because they are located in the known drainage pathway of an oral cavity neoplasm. These nodes proved to be positive for tumour after neck dissection.
Conclusion
Owing to advances in its detection and multimodality treatment, patients with head and neck cancer are living longer, long enough for their malignancies to either recur and/or metastasize. The presence or absence of nodal metastasis has a marked effect on treatment planning and patient prognosis. As a result, it is more important than ever for the radiologist to have a systematic approach to the identification of nodal metastasis. ''CRISPS'' is an easy-toremember acronym that encompasses the essential criteria of clustering, shape, inhomogeneity, size, periphery, and sentinel node. . Nodes at risk of metastatic involvement include the ipsilateral level IB nodes (short arrow). The second image shows the presence of 2 right level IB nodes, which are otherwise normal appearing in the context of the various radiographic criteria. Their radiographic suspicion is raised only by the context that they are mildly prominent and are in the primary drainage pathway of the known buccal carcinoma. These nodes were positive after neck dissection.
